Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225

British Journal of Dermatology

Volumn 144, Issue 6, 2001, Pages 1169-1176

  Busam, K J ^a   Capodieci, P ^a   Motzer, R ^a   Kiehn, T ^a   Phelan, D ^a   Halpern, A C ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

C225; Epidermal growth factor receptor; Folliculitis

Indexed keywords

CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P27;

ACANTHOLYSIS; ACNE; ADULT; AGED; APHTHOUS ULCER; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FACE; FEMALE; FINGER; FOLLICULITIS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VIVO STUDY; KERATINOCYTE; KIDNEY CARCINOMA; MALE; MORPHOLOGY; MOUTH MUCOSA; PARONYCHIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PUNCH BIOPSY; RASH; SKIN INFLAMMATION; THORAX; TOE; TREATMENT OUTCOME;

AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CARCINOMA, RENAL CELL; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DRUG ERUPTIONS; FEMALE; FOLLICULITIS; HUMANS; IMMUNOENZYME TECHNIQUES; KIDNEY NEOPLASMS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; SEVERITY OF ILLNESS INDEX; TUMOR SUPPRESSOR PROTEINS;

EID: 0035724536     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2001.04226.x     Document Type: Article

References (46)

1. Growth stimulation of A431 cells by epidermal growth factor: Identification of high-affinity receptors for epidermal growth factor by an antireceptor monoclonal antibody
2. Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors
3. The biologic effects of C225, a chimeric monoclonal antibody to the EGFR, on human prostate carcinoma
4. EGF receptor blockade induces reversible growth arrest and changes in proteins that regulate cell cycle in human epithelial cells
5. Epidermal growth factor receptor inhibition by a monoclonal antibody as anticancer therapy
6. Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies
7. Phase I studies of anti-epidermal growth factor receptor chimeric monoclonal antibody C225 in patients with EFGR overexpressing tumors
8. Distinct altered patterns of p27Kip1 gene expression in benign prostatic hyperplasia and prostatic carcinoma
9. p27 and Rb are on overlapping pathways suppressing tumorigenesis in mice
10. Distribution of epidermal growth factor receptors in rat tissues during embryonic skin development, hair formation, and the adult hair growth cycle
11. Comparison of epidermal growth factor binding and receptor distribution in normal human epidermis and epidermal appendages
12. Immunolocalization of epidermal growth factor receptors in normal developing human skin
13. Epidermal growth factor, estrogen, and progesterone receptor expression in primary sweat gland carcinomas and primary and metastatic mammary carcinomas
14. TGFα deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice
15. Mice with a null mutation of the TGFα gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation
16. Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor
17. Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure
18. Altered hair follicle morphogenesis in epidermal growth factor receptor deficient mice
19. Genetically null mice reveal a central role for epidermal growth factor receptor in the differentiation of the hair follicle and normal hair development
20. Transgenic mice provide new insights into the role of TGF-α during epidermal development and differentiation
21. Epidermal growth factor delays the development of the epidermis and hair follicles of mice during growth of the first coat
22. Effects of epidermal growth factor on hair growth in the mouse
23. The stimulation of epidermal proliferation by a specific protein (EGF)
24. Epidermal hyperplasia and wool follicle regression in sheep infused with epidermal growth factor
25. Cultivation of keratino-cytes derived from epidermal explants of sheep skin and the roles of growth factors in the regulation of proliferation
26. Targeted overexpression of transforming growth factor α in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous squamous papillomas
27. Effects of EGF on the morphology and patterns of DNA synthesis in isolated human hair follicles
28. Human hair growth in vitro: A model for the study of hair follicle biology
29. Modeling acne in vitro
30. The improved organ maintenance of the human sebaceous gland: Modeling in vitro the effects of epidermal growth factor, androgens, estrogens, 13-cis retinoic acid, and phenol red
31. Effects of interleukins, colony-stimulating factor and tumour necrosis factor on human hair follicle growth in vitro: A possible role for interleukin-1 and tumour necrosis factor-alpha in alopecia areata
32. The role of IGF-I in human skin and its appendages: Morphogen as well as mitogen?
33. The regulatory biology of the human pilosebaceous unit
34. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals
35. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest
36. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
37. Involvement of p27KIP1 in G1 arrest mediated by an anti-epidermal growth factor receptor mono-clonal antibody
38. Anti-epidermal growth factor receptor monoclonal antibody 225 upregulates p27KIP1 and induces G1 arrest in prostatic cancer cell line DU145
39. Blockade of epidermal growth factor receptor by anti-epidermal growth factor receptor monoclonal antibody C225 causes G1 arrest of A431 cells with induction of p27KIP1
40. Reciprocal changes in p27 (Kip1) and p21 (Cip1) in growth inhibition mediated by blockade or overstimulation of epidermal growth factor receptors
41. Mutation in Sos1 dominantly enhances a weak allele of the EGFR, demonstrating a requirement for Sos1 in EGFR signaling and development
42. Treatment of Menetrier's disease with a monoclonal antibody against the epidermal growth factor receptor
43. Paronychia and pyogenic granuloma-like lesions with isotretinoin
44. Excess granulation tissue during etretinate therapy
45. Paronychia associated with antiretroviral therapy